Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity
Chava Kimchi-Sarfaty,*Jung Mi Oh,In-Wha Kim,Zuben E. Sauna,Anna Maria Calcagno,Suresh V. Ambudkar,Michael M. Gottesman
Synonymous single-nucleotide polymorphisms (SNPs) do not producealtered coding sequences, and therefore they are not expectedto change the function of the protein in which they occur. Wereport that a synonymous SNP in the Multidrug Resistance 1 (MDR1)gene, part of a haplotype previously linked to altered functionof the MDR1 gene product P-glycoprotein (P-gp), nonethelessresults in P-gp with altered drug and inhibitor interactions.Similar mRNA and protein levels, but altered conformations,were found for wild-type and polymorphic P-gp. We hypothesizethat the presence of a rare codon, marked by the synonymouspolymorphism, affects the timing of cotranslational foldingand insertion of P-gp into the membrane, thereby altering thestructure of substrate and inhibitor interaction sites.
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
* Present address: Center for Biologics Evaluation and Research,Food and Drug Administration, 29 Lincoln Drive, Room 316, Bethesda,MD 20892, USA.
Present address: College of Pharmacy, Seoul National University,Seoul 151-742, South Korea.
To whom correspondence should be addressed. E-mail: mgottesman{at}nih.gov (M.M.G.); jmoh{at}snu.ac.kr (J.M.O.); kimchi{at}cber.fda.gov (C.K.-S.)
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Anton A. Komar (26 January 2007) Science315 (5811), 466.
[DOI: 10.1126/science.1138239] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.
P. L. Anderson, C. L. Aquilante, E. M. Gardner, J. Predhomme, P. McDaneld, L. R. Bushman, J.-H. Zheng, M. Ray, and S. MaWhinney (2009)
J. Antimicrob. Chemother.
64, 1071-1079
|Abstract »|Full Text »|PDF »
Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts.
M. Naesens, E. Lerut, H. de Jonge, B. Van Damme, Y. Vanrenterghem, and D. R. J. Kuypers (2009)
J. Am. Soc. Nephrol.
20, 2468-2480
|Abstract »|Full Text »|PDF »
TTA Lynx: a web-based service for analysis of actinomycete genes containing rare TTA codon.
N. Zaburannyy, B. Ostash, and V. Fedorenko (2009)
Bioinformatics
25, 2432-2433
|Abstract »|Full Text »|PDF »
Genomic Analysis of an Attenuated Chlamydia abortus Live Vaccine Strain Reveals Defects in Central Metabolism and Surface Proteins.
L. S. Burall, A. Rodolakis, A. Rekiki, G. S. A. Myers, and P. M. Bavoil (2009)
Infect. Immun.
77, 4161-4167
|Abstract »|Full Text »|PDF »
Identification of Genetic Variants Associated With Response to Statin Therapy.
J. L. Mega, D. A. Morrow, A. Brown, C. P. Cannon, and M. S. Sabatine (2009)
Arterioscler Thromb Vasc Biol
29, 1310-1315
|Abstract »|Full Text »|PDF »
Polymorphisms in Multiple Genes Contribute to the Spontaneous Mitochondrial Genome Instability of Saccharomyces cerevisiae S288C Strains.
L. N. Dimitrov, R. B. Brem, L. Kruglyak, and D. E. Gottschling (2009)
Genetics
183, 365-383
|Abstract »|Full Text »|PDF »
Positively Selected Disease Response Orthologous Gene Sets in the Cereals Identified Using Sorghum bicolor L. Moench Expression Profiles and Comparative Genomics.
A. Zamora, Q. Sun, M. T. Hamblin, C. F. Aquadro, and S. Kresovich (2009)
Mol. Biol. Evol.
26, 2015-2030
|Abstract »|Full Text »|PDF »
CACNA1C Gene Polymorphisms, Cardiovascular Disease Outcomes, and Treatment Response.
A. L. Beitelshees, H. Navare, D. Wang, Y. Gong, J. Wessel, J. I. Moss, T. Y. Langaee, R. M. Cooper-DeHoff, W. Sadee, C. J. Pepine, et al. (2009)
Circ Cardiovasc Genet
2, 362-370
|Abstract »|Full Text »|PDF »
Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia.
D. H. Kim, L. Sriharsha, W. Xu, S. Kamel-Reid, X. Liu, K. Siminovitch, H. A. Messner, and J. H. Lipton (2009)
Clin. Cancer Res.
15, 4750-4758
|Abstract »|Full Text »|PDF »
Translationally Optimal Codons Associate with Structurally Sensitive Sites in Proteins.
Locus-Specific Decoupling of Base Composition Evolution at Synonymous Sites and Introns along the Drosophila melanogaster and Drosophila sechellia Lineages.
V. L. Bauer DuMont, N. D. Singh, M. H. Wright, and C. F. Aquadro (2009)
Gen Biol Evol
2009, 67-74
|Abstract »|Full Text »|PDF »
Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism.
A. Y. Saadjian, V. Gerolami, R. Giorgi, L. Mercier, J.-L. Berge-Lefranc, F. Paganelli, Z. Ibrahim, Y. By, J. L. Gueant, S. Levy, et al. (2009)
Eur. Heart J.
30, 1510-1515
|Abstract »|Full Text »|PDF »
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
K. Lovas, C. G Gjesdal, M. Christensen, A. B Wolff, B. Almas, J. Svartberg, K. J Fougner, U. Syversen, J. Bollerslev, J. A Falch, et al. (2009)
Eur. J. Endocrinol.
160, 993-1002
|Abstract »|Full Text »|PDF »
Oncocytic, focally anaplastic, thyroid cancer responding to erlotinib.
T. Hogan, Jing Jie Yu, H J. Williams, R. Altaha, Xiaobing Liang, and Qi He (2009)
Journal of Oncology Pharmacy Practice
15, 111-117
|Abstract »|PDF »
ABCB1 Genotypes Predict Cyclosporine-Related Adverse Events and Kidney Allograft Outcome.
D. Cattaneo, P. Ruggenenti, S. Baldelli, N. Motterlini, E. Gotti, S. Sandrini, M. Salvadori, G. Segoloni, P. Rigotti, D. Donati, et al. (2009)
J. Am. Soc. Nephrol.
20, 1404-1415
|Abstract »|Full Text »|PDF »
A Comprehensive Survey of Single Nucleotide Polymorphisms (SNPs) across Mycobacterium bovis Strains and M. bovis BCG Vaccine Strains Refines the Genealogy and Defines a Minimal Set of SNPs That Separate Virulent M. bovis Strains and M. bovis BCG Strains.
M. C. Garcia Pelayo, S. Uplekar, A. Keniry, P. Mendoza Lopez, T. Garnier, J. Nunez Garcia, L. Boschiroli, X. Zhou, J. Parkhill, N. Smith, et al. (2009)
Infect. Immun.
77, 2230-2238
|Abstract »|Full Text »|PDF »
Coding-Sequence Determinants of Gene Expression in Escherichia coli.
G. Kudla, A. W. Murray, D. Tollervey, and J. B. Plotkin (2009)
Science
324, 255-258
|Abstract »|Full Text »|PDF »
Gene Mutations in Esophageal Mucosa of Chagas Disease Patients.
F. DA SILVA MANOEL-CAETANO, A. F.P. SILVEIRA, and A. E. SILVA (2009)
Anticancer Res
29, 1243-1247
|Abstract »|Full Text »|PDF »
Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory.
P. M. Greenwood, M.-K. Lin, R. Sundararajan, K. J. Fryxell, and R. Parasuraman (2009)
PNAS
106, 3633-3638
|Abstract »|Full Text »|PDF »
A Gripping Tale of Ribosomal Frameshifting: Extragenic Suppressors of Frameshift Mutations Spotlight P-Site Realignment.
J. F. Atkins and G. R. Bjork (2009)
Microbiol. Mol. Biol. Rev.
73, 178-210
|Abstract »|Full Text »|PDF »
The impact of pharmacogenetics on HIV therapy.
T W Mahungu, M A Johnson, A Owen, and D J Back (2009)
Int J STD AIDS
20, 145-151
|Abstract »|Full Text »|PDF »
Limited Brain Distribution of [3R,4R,5S]-4-Acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate Phosphate (Ro 64-0802), a Pharmacologically Active Form of Oseltamivir, by Active Efflux across the Blood-Brain Barrier Mediated by Organic Anion Transporter 3 (Oat3/Slc22a8) and Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4).
A. Ose, M. Ito, H. Kusuhara, K. Yamatsugu, M. Kanai, M. Shibasaki, M. Hosokawa, J. D. Schuetz, and Y. Sugiyama (2009)
Drug Metab. Dispos.
37, 315-321
|Abstract »|Full Text »|PDF »
Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients.
H. Chang, S. Y. Rha, H. -C. Jeung, C. -K. Im, J. B. Ahn, W. S. Kwon, N. C. Yoo, J. K. Roh, and H. C. Chung (2009)
Ann. Onc.
20, 272-277
|Abstract »|Full Text »|PDF »
Calcineurin Inhibitor Nephrotoxicity.
M. Naesens, D. R. J. Kuypers, and M. Sarwal (2009)
Clin. J. Am. Soc. Nephrol.
4, 481-508
|Abstract »|Full Text »|PDF »
Investigating Protein-Coding Sequence Evolution with Probabilistic Codon Substitution Models.
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients.
M. Schaich, L. Kestel, M. Pfirrmann, K. Robel, T. Illmer, M. Kramer, C. Dill, G. Ehninger, G. Schackert, and D. Krex (2009)
Ann. Onc.
20, 175-181
|Abstract »|Full Text »|PDF »
Farp2 and Stk25 Are Candidate Genes for the HDL Cholesterol Locus on Mouse Chromosome 1.
Z. Su, A. Cox, Y. Shen, I. M. Stylianou, and B. Paigen (2009)
Arterioscler Thromb Vasc Biol
29, 107-113
|Abstract »|Full Text »|PDF »
A Single Nucleotide Polymorphism in Pro-Apoptotique Protein BIM Affects Chronic Myeloid Leukaemia Evolution during Imatinib Treatment.
V. Augis, F. Belloc, K. Airiau, C. Chollet, and F.-X. Mahon (2008)
Blood (ASH Annual Meeting Abstracts)
112, 4227
|Abstract »|Full Text »
A Novel Human Multidrug Resistance Gene MDR1 Variant G571A (G191R) Modulates Cancer Drug Resistance and Efflux Transport.
Z. Yang, D. Wu, T. Bui, and R. J. Y. Ho (2008)
J. Pharmacol. Exp. Ther.
327, 474-481
|Abstract »|Full Text »|PDF »
Profiling Human Androgen Receptor Mutations Reveals Treatment Effects in a Mouse Model of Prostate Cancer.
O. A. O'Mahony, M. P. Steinkamp, M. A. Albertelli, M. Brogley, H. Rehman, and D. M. Robins (2008)
Mol. Cancer Res.
6, 1691-1701
|Abstract »|Full Text »|PDF »
Long-Distance, Graft-Transmissible Action of Arabidopsis FLOWERING LOCUS T Protein to Promote Flowering.
M. Notaguchi, M. Abe, T. Kimura, Y. Daimon, T. Kobayashi, A. Yamaguchi, Y. Tomita, K. Dohi, M. Mori, and T. Araki (2008)
Plant Cell Physiol.
49, 1645-1658
|Abstract »|Full Text »|PDF »
Role of GluR1 in Activity-Dependent Motor System Development.
L. Zhang, J. Schessl, M. Werner, C. Bonnemann, G. Xiong, J. Mojsilovic-Petrovic, W. Zhou, A. Cohen, P. Seeburg, H. Misawa, et al. (2008)
J. Neurosci.
28, 9953-9968
|Abstract »|Full Text »|PDF »
Accelerated sequence divergence of conserved genomic elements in Drosophila melanogaster.
A. K. Holloway, D. J. Begun, A. Siepel, and K. S. Pollard (2008)
Genome Res.
18, 1592-1601
|Abstract »|Full Text »|PDF »
From the Cover: Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity.
C. A. Sarkar, I. Dodevski, M. Kenig, S. Dudli, A. Mohr, E. Hermans, and A. Pluckthun (2008)
PNAS
105, 14808-14813
|Abstract »|Full Text »|PDF »
ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy.
S. E. Johnatty, J. Beesley, J. Paul, S. Fereday, A. B. Spurdle, P. M. Webb, K. Byth, S. Marsh, H. McLeod, AOCS Study Group, et al. (2008)
Clin. Cancer Res.
14, 5594-5601
|Abstract »|Full Text »|PDF »
ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
T. Ernst, J. Hoffmann, P. Erben, B. Hanfstein, A. Leitner, R. Hehlmann, A. Hochhaus, and M. C. Muller (2008)
Haematologica
93, 1389-1393
|Abstract »|Full Text »|PDF »
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.
S. Dulucq, S. Bouchet, B. Turcq, E. Lippert, G. Etienne, J. Reiffers, M. Molimard, M. Krajinovic, and F.-X. Mahon (2008)
Blood
112, 2024-2027
|Abstract »|Full Text »|PDF »
Association of a Polymorphism Near CREB1 With Differential Aversion Processing in the Insula of Healthy Participants.
R. H. Perlis, D. J. Holt, J. W. Smoller, A. J. Blood, S. Lee, B. W. Kim, M. J. Lee, M. Sun, N. Makris, D. K. Kennedy, et al. (2008)
Arch Gen Psychiatry
65, 882-892
|Abstract »|Full Text »|PDF »
Presence of a TA Haplotype in the APC Gene Containing the Common 1822 Polymorphism and Colorectal Adenoma.
J. B. Egan, E. T. Jacobs, M. E. Martinez, E. W. Gerner, P. W. Jurutka, and P. A. Thompson (2008)
Cancer Res.
68, 6006-6013
|Abstract »|Full Text »|PDF »
Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate.
B. T. Chiquet, S. H. Blanton, A. Burt, D. Ma, S. Stal, J. B. Mulliken, and J. T. Hecht (2008)
Hum. Mol. Genet.
17, 2212-2218
|Abstract »|Full Text »|PDF »
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.
O. Levran, K. O'Hara, E. Peles, D. Li, S. Barral, B. Ray, L. Borg, J. Ott, M. Adelson, and M. J. Kreek (2008)
Hum. Mol. Genet.
17, 2219-2227
|Abstract »|Full Text »|PDF »
ABCB1 Genetic Variation Influences the Toxicity and Clinical Outcome of Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel.
T. M. Sissung, C. E. Baum, J. Deeken, D. K. Price, J. Aragon-Ching, S. M. Steinberg, W. Dahut, A. Sparreboom, and W. D. Figg (2008)
Clin. Cancer Res.
14, 4543-4549
|Abstract »|Full Text »|PDF »
Cervical and Vulvar Cancer Risk in Relation to the Joint Effects of Cigarette Smoking and Genetic Variation in Interleukin 2.
S. K. Hussain, M. M. Madeleine, L. G. Johnson, Q. Du, M. Malkki, H.-W. Wilkerson, F. M. Farin, J. J. Carter, D. A. Galloway, J. R. Daling, et al. (2008)
Cancer Epidemiol. Biomarkers Prev.
17, 1790-1799
|Abstract »|Full Text »|PDF »
Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms.
J. M. Gow, L. M. Hodges, L. W. Chinn, and D. L. Kroetz (2008)
J. Pharmacol. Exp. Ther.
325, 435-442
|Abstract »|Full Text »|PDF »
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
M. H. Tomasson, Z. Xiang, R. Walgren, Y. Zhao, Y. Kasai, T. Miner, R. E. Ries, O. Lubman, D. H. Fremont, M. D. McLellan, et al. (2008)
Blood
111, 4797-4808
|Abstract »|Full Text »|PDF »
Genetic variation in the CRP promoter: association with systemic lupus erythematosus.
J. C. Edberg, J. Wu, C. D. Langefeld, E. E. Brown, M. C. Marion, G. McGwin Jr, M. Petri, R. Ramsey-Goldman, J. D. Reveille, S. G. Frank, et al. (2008)
Hum. Mol. Genet.
17, 1147-1155
|Abstract »|Full Text »|PDF »
Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans.
R. Manoharlal, N. A. Gaur, S. L. Panwar, J. Morschhauser, and R. Prasad (2008)
Antimicrob. Agents Chemother.
52, 1481-1492
|Abstract »|Full Text »|PDF »
Modulation of Na+-Ca2+ Exchanger Expression by Immunosuppressive Drugs Is Isoform-Specific.
B. Elbaz, A. Alperovitch, M. M. Gottesman, C. Kimchi-Sarfaty, and H. Rahamimoff (2008)
Mol. Pharmacol.
73, 1254-1263
|Abstract »|Full Text »|PDF »
Where Do We Go for Atherothrombotic Disease Genetics?.
S.-M. Brand-Herrmann (2008)
Stroke
39, 1070-1075
|Full Text »|PDF »
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus.
A H Sawalha, K M Kaufman, J A Kelly, A J Adler, T Aberle, J Kilpatrick, E K Wakeland, Q-Z Li, A E Wandstrat, D R Karp, et al. (2008)
Ann Rheum Dis
67, 458-461
|Abstract »|Full Text »|PDF »
Mammalian Nonsynonymous Sites Are Not Overdispersed: Comparative Genomic Analysis of Index of Dispersion of Mammalian Proteins.
Functionally significant insulin-like growth factor I receptor mutations in centenarians.
Y. Suh, G. Atzmon, M.-O. Cho, D. Hwang, B. Liu, D. J. Leahy, N. Barzilai, and P. Cohen (2008)
PNAS
105, 3438-3442
|Abstract »|Full Text »|PDF »
Applying Gene Expression, Proteomics and Single-Nucleotide Polymorphism Analysis for Complex Trait Gene Identification.
I. M. Stylianou, J. P. Affourtit, K. R. Shockley, R. Y. Wilpan, F. A. Abdi, S. Bhardwaj, J. Rollins, G. A Churchill, and B. Paigen (2008)
Genetics
178, 1795-1805
|Abstract »|Full Text »|PDF »
Mutation-Selection Models of Codon Substitution and Their Use to Estimate Selective Strengths on Codon Usage.
P-glycoprotein Restricts the Penetration of Oseltamivir Across the Blood-Brain Barrier.
A. Ose, H. Kusuhara, K. Yamatsugu, M. Kanai, M. Shibasaki, T. Fujita, A. Yamamoto, and Y. Sugiyama (2008)
Drug Metab. Dispos.
36, 427-434
|Abstract »|Full Text »|PDF »
Alternative approach to a heavy weight problem.
A. Goren, E. Kim, M. Amit, R. Bochner, G. Lev-Maor, N. Ahituv, and G. Ast (2008)
Genome Res.
18, 214-220
|Abstract »|Full Text »|PDF »
Fitting Periplasmic Membrane Fusion Proteins to Inner Membrane Transporters: Mutations That Enable Escherichia coli AcrA To Function with Pseudomonas aeruginosa MexB.
G. Krishnamoorthy, E. B. Tikhonova, and H. I. Zgurskaya (2008)
J. Bacteriol.
190, 691-698
|Abstract »|Full Text »|PDF »
Lack of Association Between the MEF2A Gene and Myocardial Infarction.
W. Lieb, B. Mayer, I. R. Konig, I. Borwitzky, A. Gotz, S. Kain, C. Hengstenberg, P. Linsel-Nitschke, M. Fischer, A. Doring, et al. (2008)
Circulation
117, 185-191
|Abstract »|Full Text »|PDF »
Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea.
T. D. Gallardo, G. B. John, K. Bradshaw, C. Welt, R. Reijo-Pera, P. H. Vogt, P. Touraine, S. Bione, D. Toniolo, L. M. Nelson, et al. (2008)
Hum. Reprod.
23, 216-221
|Abstract »|Full Text »|PDF »
GATA4 sequence variants in patients with congenital heart disease.
A Tomita-Mitchell, C L Maslen, C D Morris, V Garg, and E Goldmuntz (2007)
J. Med. Genet.
44, 779-783
|Abstract »|Full Text »|PDF »
Sequential Influences of Leukemia-Specific and Genetic Factors on P-Glycoprotein Expression in Blasts from 817 Patients Entered into the National Cancer Research Network Acute Myeloid Leukemia 14 and 15 Trials.
C. H. Seedhouse, M. Grundy, P. White, Y. Li, J. Fisher, D. Yakunina, A. V. Moorman, T. Hoy, N. Russell, A. Burnett, et al. (2007)
Clin. Cancer Res.
13, 7059-7066
|Abstract »|Full Text »|PDF »
Patterns of Mutation and Selection at Synonymous Sites in Drosophila.
N. D. Singh, V. L. Bauer DuMont, M. J. Hubisz, R. Nielsen, and C. F. Aquadro (2007)
Mol. Biol. Evol.
24, 2687-2697
|Abstract »|Full Text »|PDF »
ERCC1 Genotype and Phenotype in Epithelial Ovarian Cancer Identify Patients Likely to Benefit From Paclitaxel Treatment in Addition to Platinum-Based Therapy.
S. Smith, D. Su, I. A. Rigault de la Longrais, P. Schwartz, M. Puopolo, T. J. Rutherford, G. Mor, H. Yu, and D. Katsaros (2007)
J. Clin. Oncol.
25, 5172-5179
|Abstract »|Full Text »|PDF »
Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells.
S. M. Garcia, M. O. Casanueva, M. C. Silva, M. D. Amaral, and R. I. Morimoto (2007)
Genes & Dev.
21, 3006-3016
|Abstract »|Full Text »|PDF »
Suppressor Mutations in the Transmembrane Segments of P-glycoprotein Promote Maturation of Processing Mutants and Disrupt a Subset of Drug-binding Sites.
T. W. Loo, M. C. Bartlett, and D. M. Clarke (2007)
J. Biol. Chem.
282, 32043-32052
|Abstract »|Full Text »|PDF »
Association of Polymorphisms in Odorant-Binding Protein Genes With Variation in Olfactory Response to Benzaldehyde in Drosophila.
P. Wang, R. F. Lyman, S. A. Shabalina, T. F. C. Mackay, and R. R. H. Anholt (2007)
Genetics
177, 1655-1665
|Abstract »|Full Text »|PDF »
Congenic Interval Mapping of RNO10 Reveals a Complex Cluster of Closely-Linked Genetic Determinants of Blood Pressure.
Y. Saad, S. Yerga-Woolwine, J. Saikumar, P. Farms, E. Manickavasagam, E. J. Toland, and B. Joe (2007)
Hypertension
50, 891-898
|Abstract »|Full Text »|PDF »
Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer.
Z. E. Sauna, C. Kimchi-Sarfaty, S. V. Ambudkar, and M. M. Gottesman (2007)
Cancer Res.
67, 9609-9612
|Abstract »|Full Text »|PDF »
Organismal complexity, cell differentiation and gene expression: human over mouse.
A. E. Vinogradov and O. V. Anatskaya (2007)
Nucleic Acids Res.
35, 6350-6356
|Abstract »|Full Text »|PDF »
CRISPLD2: a novel NSCLP candidate gene.
B. T. Chiquet, A. C. Lidral, S. Stal, J. B. Mulliken, L. M. Moreno, M. Arco-Burgos, C. Valencia-Ramirez, S. H. Blanton, and J. T. Hecht (2007)
Hum. Mol. Genet.
16, 2241-2248
|Abstract »|Full Text »|PDF »
Raising the estimate of functional human sequences.
Mitochondrial Genetic Polymorphisms and Pancreatic Cancer Risk.
L. Wang, W. R. Bamlet, M. de Andrade, L. A. Boardman, J. M. Cunningham, S. N. Thibodeau, and G. M. Petersen (2007)
Cancer Epidemiol. Biomarkers Prev.
16, 1455-1459
|Abstract »|Full Text »|PDF »
Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae.
E. Lamping, B. C. Monk, K. Niimi, A. R. Holmes, S. Tsao, K. Tanabe, M. Niimi, Y. Uehara, and R. D. Cannon (2007)
Eukaryot. Cell
6, 1150-1165
|Abstract »|Full Text »|PDF »
MDR1 Gene Variants, Indoor Insecticide Exposure, and the Risk of Childhood Acute Lymphoblastic Leukemia.
K. Y. Urayama, J. K. Wiencke, P. A. Buffler, A. P. Chokkalingam, C. Metayer, and J. L. Wiemels (2007)
Cancer Epidemiol. Biomarkers Prev.
16, 1172-1177
|Abstract »|Full Text »|PDF »
Clinical Pharmacogenetics of the Major Adenosine Triphosphate Binding Cassette and Solute Carrier Drug Transporters.
D. S. Streetman (2007)
Journal of Pharmacy Practice
20, 219-233
|Abstract »|PDF »
Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genome.
E. H. Margulies, G. M. Cooper, G. Asimenos, D. J. Thomas, C. N. Dewey, A. Siepel, E. Birney, D. Keefe, A. S. Schwartz, M. Hou, et al. (2007)
Genome Res.
17, 760-774
|Abstract »|Full Text »|PDF »
A new strategy for assessing selenoprotein function: siRNA knockdown/knock-in targeting the 3'-UTR.
M.-H. Yoo, X.-M. Xu, A. A. Turanov, B. A. Carlson, V. N. Gladyshev, and D. L. Hatfield (2007)
RNA
13, 921-929
|Abstract »|Full Text »|PDF »
Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck.
S. Zhou, S. Kachhap, W. Sun, G. Wu, A. Chuang, L. Poeta, L. Grumbine, S. K. Mithani, A. Chatterjee, W. Koch, et al. (2007)
PNAS
104, 7540-7545
|Abstract »|Full Text »|PDF »